LONDON (Reuters) - Coffee shops, burger bars and clothes stores are among the foreign businesses in China that say they are thriving despite the economic slowdown that is hurting the manufacturing sector.
SINGAPORE (Reuters) - U.S. crude fell for a second session in early Asian trade on Tuesday as worries about the economic health of top energy consumer China and rising oil supply weighed on markets.
TOKYO (Reuters) - Asian shares wobbled on Tuesday as crude oil prices slid on rekindled oversupply fears and after downbeat manufacturing data raised concerns about global momentum.
CHICAGO (Reuters) - Democrats from Pennsylvania's congressional delegation sent a letter to a federal rail regulator on Monday raising concerns over the possible negative impacts of a merger between Canadian Pacific and Norfolk Southern Corp.
HAVANA (Reuters) - Bacardi on Monday sought U.S. records to explain the U.S. government's decision to strip the spirits company of its right to the Havana Club brand name and hand it back to a Cuban state company partnered with a global rival.
(Reuters) - Alphabet Inc reported better-than-expected quarterly profit on Monday, sending shares of Google's parent soaring in after-hours trading and making it the most valuable U.S. company ahead of rival Apple Inc.
WASHINGTON/KUALA LUMPUR (Reuters) - Switzerland's chief prosecutor said on Friday a criminal investigation into state fund 1Malaysia Development Berhad (1MDB) had revealed that about $4 billion appeared to have been misappropriated from Malaysian state companies.
WASHINGTON (Reuters) - Banks lowered lending standards for U.S. households in the fourth quarter but tightened them for commercial and industrial loans, according to a survey of loan officers released on Monday by the Federal Reserve.
NEW YORK (Reuters) - The U.S. economy could suffer with inflation remaining too low if recent volatility in financial markets persists and signals a slowdown in the global economy, the Federal Reserve's second-in-command said on Monday.
(Reuters) - Abbott Laboratories said it would buy Alere Inc for $5.8 billion to become a leader in point-of-care testing, a fast-growing market as physicians increasingly adopt rapid tests that speed up treatment.